Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format

Eating Behaviors

Volumn 15, Issue 1, 2014, Pages 68-71

  Milsom, Vanessa A ^a   Malcolm, Robert J ^a   Johnson, Gail C ^a   Pechon, Susan M ^a   Gray, Kevin M ^a   Miller Kovach, Karen ^b   Rost, Stephanie L ^b   O'Neil, Patrick M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Weight Watchers International ^*  (United States)

Author keywords

Cardiovascular risk factors; Dieting; Obesity; Weight loss

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMMERCIAL FORMAT; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; WEIGHT CHANGE; WEIGHT REDUCTION;

CARDIOVASCULAR RISK FACTORS; DIETING; OBESITY; WEIGHT LOSS;

ADULT; BEHAVIOR THERAPY; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PROGRAM EVALUATION; RISK FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84887539277     PISSN: 14710153     EISSN: 18737358     Source Type: Journal    
DOI: 10.1016/j.eatbeh.2013.10.004     Document Type: Article

References (21)

1. Bray G.A. Medical consequences of obesity. Journal of Clinical Endocrinology and Metabolism 2004, 89:2583-2589.
2. Finley C.E., Barlow C.E., Greenway F.L., Rock C.L., Rolls B.J., Blair S.N. Retention rates and weight loss in a commercial weight loss program. International Journal of Obesity 2007, 31:292-298.
3. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
4. Gannon M.C., Nuttall F.Q. Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutrition & Metabolism 2006, 3:16.
5. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
6. Heshka S., Anderson J.W., Atkinson R.L., Greenway F.L., Hill J.O., Phinney S.D., et al. Weight loss with self-help compared with a structured commercial program: A randomized trial. JAMA 2003, 289:1792-1798.
7. Jebb S.A., Ahern A.L., Olson A.D., Aston L.M., Holzapfel A., Stoll J., et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: A randomised controlled trial. The Lancet 2011, (9/8/2011). 10.1016/S0140-6736(11)61186-0.
8. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine 2002, 346:393-403.
9. Look AHEAD Research Group & Wing, R.R. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Four-year results of the Look AHEAD trial. Archives of Internal Medicine 2010, 170:1566-1575.
10. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
11. Nicolosi R.J., Wilson T.A., Lawton C., Handelman G.J. Dietary effects on cardiovascular disease risk factors: Beyond saturated fatty acids and cholesterol. Journal of the American College of Nutrition 2001, 20:421S-427S.
12. O'Neil P.M., Theim K.R., Boeka A., Johnson G., Miller-Kovach K. Changes in weight control behaviors and hedonic hunger during a 12-week commercial weight loss program. Eating Behaviors 2012, 13:354-360.
13. Obarzanek E., Sacks F.M., Vollmer W.M., Bray G.A., Miller E.R., Lin P.H., et al. Effects on blood lipids of a blood pressure-lowering diet: The Dietary Approaches to Stop Hypertension (DASH) trial. The American Journal of Clinical Nutrition 2001, 74:80-89.
14. Pi-Sunyer X. The medical risks of obesity. Postgraduate Medicine 2009, 121:21-33.
15. Rippe J.M., Price J.M., Hess S.A., Kline G., DeMers K.A., Damitz S., et al. Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. Obesity 1998, 6:208-218.
16. Rock C.L., Flatt S.W., Sherwood N.E., Karania N., Pakiz B., Thomson C.A. Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: A randomized controlled trial. JAMA 2010, 304:1803-1810.
17. Rock C.L., Pakiz B., Flatt S.W., Quintana E.L. Randomized trial of a multifaceted commercial weight loss program. Obesity 2007, 15:939-949.
18. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. The New England Journal of Medicine 2001, 344:3-10.
19. Stevens V.J., Obarzanek E., Cook N.R., Appel L.J., Smith West D., Milas N.C., et al. Long-term weight loss and changes in blood pressure: Results of the trials of hypertension prevention, phase II. Annals of Internal Medicine 2001, 134:1-11.
20. Tsai A.G., Wadden T.A. Systematic review: An evaluation of major commercial weight loss programs in the United States. Annals of Internal Medicine 2005, 142:56-66.
21. Wang F., McDonald T., Bender J., Reffitt B., Miller A., Edington D.W. Association of healthcare costs with per unit body mass index increase. Journal of Occupational and Environmental Medicine 2006, 48:668-674.